Predictiv AI Announces Sale Of 34 ThermalPass Devices

Predictiv AI (TSXV: PAI) continues to see orders flow in for its ThermalPass fever detection system. The company this morning provided a further update on the sales exhibited by the sensor based screening system, with the announcement of an additional 34 units being sold.

The 34 units have been sold since the company’s previous announcement related to sales in early December. The additional units were reportedly sold to aboriginal communities, prisons, hospitals and public schools across both Canada and the US. The company is currently focusing on sales expansion across a number of sectors, including retail, professional sports, cruise lines, manufacturers, and a number of corporations.

Total sales figures have hit 62 devices as of the latest update, with the devices being officially on the market for a period of seven weeks. While early stage figures, the company has referred to these sales as being “foundational,” stating, “we see strong potential to receive large batch orders from these same customers in Q1 2021 and beyond.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Predictiv AI last traded at $0.18 on the TSX Venture.


FULL DISCLOSURE: Predictiv AI Inc is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Predictiv AI Inc on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Everybody Should Own Gold | George Bee – U.S. Gold Corp.

A $40M Company Created $2B in Mining Value | John-Mark Staude – Riverside Resources

The Debt Crisis Is Turning Gold Into Money | Shawn Khunkhun – Contango Silver and Gold

Recommended

Power Metallic Starts PEA on Lion and Nisk Main Deposits, Eyes First Half 2027 Completion

Cambria Gold Targets Q4 2027 Mill Restart at Premier as Red Mountain Road Clears Final Permit

Related News

Therma Bright Improves COVID-19 Rapid Saliva Antigen Test To 86% Sensitivity, 100% Specificity

Therma Bright Inc (TSXV: THRM) this afternoon halted its equity from trading for the dying...

Monday, January 18, 2021, 04:22:30 PM

Revive Submits for IRB Approval; Expects to Enroll Patients in September

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial...

Wednesday, August 26, 2020, 10:07:43 AM

#PfizerExposed: Did Pfizer Just Admit To “Engineering” Virus For COVID-19 Pill In Response To Project Veritas Video?

After a video of a top Pfizer (NYSE: PFE) executive relaying that the biotech firm...

Saturday, January 28, 2023, 10:59:30 AM

Medicago, GSK Report 71% Efficacy Rate From Plant-Based COVID-19 Vaccine Study

Quebec-based biopharmaceutical firm Medicago and healthcare conglomerate GlaxoSmithKline (NYSE: GSK) announce today the results from...

Tuesday, December 7, 2021, 11:21:00 AM

Singapore Airlines Launches First Ever Covid-19 Health Passport in Bid to Revive Air Travel Confidence

As air travel continues to remain significantly subdued amid the pandemic, several airlines have been...

Saturday, December 26, 2020, 03:52:00 PM